How bacteria develop resistance to programmable antibiotics
Antimicrobial resistance is one of the greatest challenges facing modern medicine. A new class of programmable antibiotics known as asobiotics can be used to treat bacterial infections when classical antibiotics fail. A team of researchers from TWINCORE, Center for Experimental and Clinical Infection Research; the RESIST Cluster of Excellence; and the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now studied how bacteria adapt to asobiotics. They recently published…
Phys.org
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Phys.org.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Phys.org (phys.org), a Tier B publisher, filed this report on . CurrentWire published this page 20 minutes later, on .
Signal breakdown
CurrentWire ranked this story 58.7 of 100 in the snapshot this page was rendered from.
- Freshness
- 29.2 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 29.2 of 35. How each signal is calculated.
Filed under Science · International · News.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.